DKT WomanCare and Shanghai Dahua Pharmaceutical Reduce Price of Levoplant™ to $6.70, Increasing Affordability for FP2020 Countries, Despite Widespread Challenges Due to Covid-19
9 Jun '21

DKT WomanCare and Shanghai Dahua Pharmaceutical Reduce Price of Levoplant™ to $6.70, Increasing Affordability for FP2020 Countries, Despite Widespread Challenges Due to Covid-19

June 9, 2021
  • 384 Views
  • 0 Likes
Closing the Gender Equity Health Gap Worsened by COVID-19, DKT International Celebrates Efforts to Provide Women With Essential Access to Contraceptive Options For International Day of Action for Women’s Health
Decoding India’s Stagnant Condom Market

Subscribe To Our Newsletter

Thank you for subscribing! Keep an eye on your inbox for the latest from DKT International.